Differential Receptor Subunit Affinities of Type I Interferons Govern Differential Signal Activation

Journal of Molecular Biology

Volumn 366, Issue 2, 2007, Pages 525-539

  Jaks, Eva ^a   Gavutis, Martynas ^a   Uzé, Gilles ^b   Martal, Jacques ^c   Piehler, Jacob ^a  

^a GOETHE UNIVERSITY   (Germany)

^b CNRS   (France)

^c CEMAGREF   (France)

Author keywords

interferon alpha; interferon beta; protein protein interaction; solid supported membrane; type I interferon receptor

Indexed keywords

ALPHA INTERFERON; ALPHA1 INTERFERON; ALPHA2 INTERFERON; ALPHA21 INTERFERON; ALPHA8 INTERFERON; BETA1A INTERFERON; CELL SURFACE RECEPTOR; INTERFERON; INTERFERON RECEPTOR; INTERFERON STIMULATED GENE FACTOR 3; MUTANT PROTEIN; OMEGA INTERFERON; PROTEIN IFNAR1; PROTEIN IFNAR2; RECEPTOR SUBUNIT; TAU INTERFERON; TAU2 INTERFERON; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; BINDING ASSAY; BINDING COMPETITION; CELL PROLIFERATION; COMPLEX FORMATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG POTENCY; DRUG RECEPTOR BINDING; FEMALE; FLUORESCENCE SPECTROSCOPY; HELA CELL; HUMAN; HUMAN CELL; MEMBRANE; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROTEIN DOMAIN; RECEPTOR AFFINITY; RECEPTOR BINDING; REFLECTOMETRY; SIGNAL TRANSDUCTION; SOLID;

OVIS;

EID: 33846345778     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2006.11.053     Document Type: Article

References (45)

1. Belardelli F., and Ferrantini M. Cytokines as a link between innate and adaptive antitumor immunity. Trends Immunol. 23 (2002) 201-208
2. Mogensen K.E., Lewerenz M., Reboul J., Lutfalla G., and Uze G. The type I interferon receptor: structure, function, and evolution of a family business. J. Interferon Cytokine Res. 19 (1999) 1069-1098
3. Pestka S., Krause C.D., and Walter M.R. Interferons, interferon-like cytokines, and their receptors. Immunol. Rev. 202 (2004) 8-32
4. Croze E., Russell-Harde D., Wagner T.C., Pu H., Pfeffer L.M., and Perez H.D. The human type I interferon receptor. Identification of the interferon beta-specific receptor-associated phosphoprotein. J. Biol. Chem. 271 (1996) 33165-33168
5. Domanski P., Nadeau O.W., Platanias L.C., Fish E., Kellum M., Pitha P., and Colamonici O.R. Differential use of the betaL subunit of the type I interferon (IFN) receptor determines signaling specificity for IFNalpha2 and IFNbeta. J. Biol. Chem. 273 (1998) 3144-3147
6. Rani M.R., Foster G.R., Leung S., Leaman D., Stark G.R., and Ransohoff R.M. Characterization of beta-R1, a gene that is selectively induced by interferon beta (IFN-beta) compared with IFN-alpha. J. Biol. Chem. 271 (1996) 22878-22884
7. Abramovich C., Shulman L.M., Ratovitski E., Harroch S., Tovey M., Eid P., and Revel M. Differential tyrosine phosphorylation of the IFNAR chain of the type I interferon receptor and of an associated surface protein in response to IFN-alpha and IFN-beta. EMBO J. 13 (1994) 5871-5877
8. Platanias L.C., Uddin S., Domanski P., and Colamonici O.R. Differences in interferon alpha and beta signaling. Interferon beta selectively induces the interaction of the alpha and betaL subunits of the type I interferon receptor. J. Biol. Chem. 271 (1996) 23630-23633
9. Coelho L.F., de Freitas Almeida G.M., Mennechet F.J., Blangy A., and Uze G. Interferon-{alpha} and -{beta} differentially regulate osteoclastogenesis: role of differential induction of chemokine CXCL11 expression. Proc. Natl Acad. Sci. USA 102 (2005) 11917-11922
10. Deonarain R., Chan D.C., Platanias L.C., and Fish E.N. Interferon-alpha/beta-receptor interactions: a complex story unfolding. Curr. Pharm. Des. 8 (2002) 2131-2137
11. Subramaniam P.S., Larkin III J., Mujtaba M.G., Walter M.R., and Johnson H.M. The COOH-terminal nuclear localization sequence of interferon gamma regulates STAT1 alpha nuclear translocation at an intracellular site. J. Cell Sci. 113 (2000) 2771-2781
12. da Silva A.J., Brickelmaier M., Majeau G.R., Lukashin A.V., Peyman J., Whitty A., and Hochman P.S. Comparison of gene expression patterns induced by treatment of human umbilical vein endothelial cells with IFN-alpha 2b vs. IFN-beta 1a: understanding the functional relationship between distinct type I interferons that act through a common receptor. J. Interferon Cytokine Res. 22 (2002) 173-188
13. Der S.D., Zhou A., Williams B.R., and Silverman R.H. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc. Natl Acad. Sci. USA 95 (1998) 15623-15628
14. de Veer M.J., Holko M., Frevel M., Walker E., Der S., Paranjape J.M., et al. Functional classification of interferon-stimulated genes identified using microarrays. J. Leukoc. Biol. 69 (2001) 912-920
15. Pearce Jr. K.H., Cunningham B.C., Fuh G., Teeri T., and Wells J.A. Growth hormone binding affinity for its receptor surpasses the requirements for cellular activity. Biochemistry 38 (1999) 81-89
16. Lewerenz M., Mogensen K.E., and Uze G. Shared receptor components but distinct complexes for alpha and beta interferons. J. Mol. Biol. 282 (1998) 585-599
17. Piehler J., and Schreiber G. Mutational and structural analysis of the binding interface between type I interferons and their receptor ifnar2. J. Mol. Biol. 294 (1999) 223-237
18. Runkel L., Pfeffer L., Lewerenz M., Monneron D., Yang C.H., Murti A., et al. Differences in activity between alpha and beta type I interferons explored by mutational analysis. J. Biol. Chem. 273 (1998) 8003-8008
19. Piehler J., Roisman L.C., and Schreiber G. New structural and functional aspects of the type I interferon-receptor interaction revealed by comprehensive mutational analysis of the binding interface. J. Biol. Chem. 275 (2000) 40425-40433
20. Runkel L., deDios C., Karpusas M., Betzenhauser M., Muldowney C., Zafari M., et al. Systematic mutational mapping of sites on human interferon-beta-1a that are important for receptor binding and functional activity. Biochemistry 39 (2000) 2538-2551
21. Lamken P., Lata S., Gavutis M., and Piehler J. Ligand-induced assembling of the type I interferon receptor on supported lipid bilayers. J. Mol. Biol. 341 (2004) 303-318
22. Roisman L.C., Piehler J., Trosset J.Y., Scheraga H.A., and Schreiber G. Structure of the interferon-receptor complex determined by distance constraints from double-mutant cycles and flexible docking. Proc. Natl Acad. Sci. USA 98 (2001) 13231-13236
23. Cutrone E.C., and Langer J.A. Identification of critical residues in bovine IFNAR-1 responsible for interferon binding. J. Biol. Chem. 276 (2001) 17140-17148
24. Cajean-Feroldi C., Nosal F., Nardeux P.C., Gallet X., Guymarho J., Baychelier F., et al. Identification of residues of the IFNAR1 chain of the type I human interferon receptor critical for ligand binding and biological activity. Biochemistry 43 (2004) 12498-12512
25. Lamken P., Gavutis M., Peters I., Van der Heyden J., Uze G., and Piehler J. Functional cartography of the extracellular domain of the type I interferon receptor subunit ifnar1. J. Mol. Biol. 350 (2005) 476-488
26. Lamken L., Lata S., Gavutis M., and Piehler J. Ligand-induced assembling of the type I interferon receptor on supported lipid bilayers. J. Mol. Biol. 341 (2004) 303-318
27. Gavutis M., Lata S., Lamken P., Müller P., and Piehler J. Lateral ligand-receptor interactions on membranes probed by simultaneous fluorescence-interference detection. Biophys. J. 88 (2005) 4289-4302
28. Hu R., Bekisz J., Schmeisser H., McPhie P., and Zoon K. Human IFN-alpha protein engineering: the amino acid residues at positions 86 and 90 are important for antiproliferative activity. J. Immunol. 167 (2001) 1482-1489
29. Jaitin D.A., Roisman L.C., Jaks E., Gavutis M., Piehler J., Van der Heyden J., et al. Inquiring into the differential action of interferons (IFNs): an IFN-{alpha}2 mutant with enhanced affinity to IFNAR1 is functionally similar to IFN-{beta}. Mol. Cell. Biol. 26 (2006) 1888-1897
30. Assal-Meliani A., Charpigny G., Reinaud P., Martal J., and Chaouat G. Recombinant ovine trophoblastin (roTP) inhibits ovine, murine and human lymphocyte proliferation. J. Reprod. Immunol. 25 (1993) 149-165
31. Subramaniam P.S., Khan S.A., Pontzer C.H., and Johnson H.M. Differential recognition of the type I interferon receptor by interferons tau and alpha is responsible for their disparate cytotoxicities. Proc. Natl Acad. Sci. USA 92 (1995) 12270-12274
32. Martal J.L., Chene N.M., Huynh L.P., L'Haridon R.M., Reinaud P.B., Guillomot M.W., et al. IFN-tau: a novel subtype I IFN1. Structural characteristics, non-ubiquitous expression, structure-function relationships, a pregnancy hormonal embryonic signal and cross-species therapeutic potentialities. Biochimie 80 (1998) 755-777
33. Lata S., and Piehler J. Stable and functional immobilization of histidine-tagged proteins via multivalent chelator head-groups on a molecular poly(ethylene glycol) brush. Anal. Chem. 77 (2005) 1096-1105
34. Lu J., Chuntharapai A., Beck J., Bass S., Ow A., De Vos A.M., et al. Structure-function study of the extracellular domain of the human IFN-alpha receptor (hIFNAR1) using blocking monoclonal antibodies: the role of domains 1 and 2. J. Immunol. 160 (1998) 1782-1788
35. Roisman L.C., Jaitin D., Baker D.P., and Schreiber G. Mutational analysis of the IFNAR1 binding site on IFNalpha2 reveals the architecture of a weak ligand-receptor binding-site. J. Mol. Biol. 353 (2005) 271-281
36. Piehler J., and Schreiber G. Biophysical analysis of the interaction of human ifnar2 expressed in E.coli with IFN alpha 2. J. Mol. Biol. 289 (1999) 57-67
37. Gavutis M., Jaks E., Lamken P., and Piehler J. Determination of the 2-dimensional interaction rate constants of a cytokine receptor complex. Biophys. J. 90 (2006) 3345-5335
38. Whitty A., Raskin N., Olson D.L., Borysenko C.W., Ambrose C.M., Benjamin C.D., and Burkly L.C. Interaction affinity between cytokine receptor components on the cell surface. Proc. Natl Acad. Sci. USA 95 (1998) 13165-13170
39. Schoner B.E., Belagaje R.M., and Schoner R.G. Enhanced translational efficiency with two-cistron expression system. Methods Enzymol. 185 (1990) 94-103
40. Martal J., Degryse E., Charpigny G., Assal N., Reinaud P., Charlier M., et al. Evidence for extended maintenance of the corpus luteum by uterine infusion of a recombinant trophoblast alpha-interferon (trophoblastin) in sheep. J. Endocrinol. 127 (1990) R5-R8
41. Degryse E., Dietrich M., Nguyen M., Achstetter T., Charlier M., Charpigny G., et al. Addition of a dipeptide spacer significantly improves secretion of ovine trophoblast interferon in yeast. Gene 118 (1992) 47-53
42. Piehler J., and Schreiber G. Fast transient cytokine-receptor interactions monitored in real time by reflectometric interference spectroscopy. Anal. Biochem. 289 (2001) 173-186
43. Schmitt H.M., Brecht A., Piehler J., and Gauglitz G. An integrated system for optical biomolecular interaction analysis. Biosens. Bioelect. 12 (1997) 809-816
44. Guex N., and Peitsch M.C. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 18 (1997) 2714-2723
45. Whitty A., and Borysenko C.W. Small molecule cytokine mimetics. Chem. Biol. 6 (1999) R107-R118